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Abstract Since the genetic basis for Down syndrome
(DS) was described, understanding the causative relation-
ship between genes at dosage imbalance and phenotypes
associated with DS has been a principal goal of researchers
studying trisomy 21 (Ts21). Though inferences to the gene-
phenotype relationship in humans have been made, evi-
dence linking a speciﬁc gene or region to a particular
congenital phenotype has been limited. To further under-
stand the genetic basis for DS phenotypes, mouse models
with three copies of human chromosome 21 (Hsa21) or-
thologs have been developed. Mouse models offer access
to every tissue at each stage of development, opportunity to
manipulate genetic content, and ability to precisely quan-
tify phenotypes. Numerous approaches to recreate trisomic
composition and analyze phenotypes similar to DS have
resulted in diverse trisomic mouse models. A murine
intraspecies comparative analysis of different genetic
models of Ts21 and speciﬁc DS phenotypes reveals the
complexity of trisomy and important considerations to
understand the etiology of and strategies for amelioration
or prevention of trisomic phenotypes. By analyzing indi-
vidual phenotypes in different mouse models throughout
development, such as neurologic, craniofacial, and car-
diovascular abnormalities, greater insight into the gene-
phenotype relationship has been demonstrated. In this
review we discuss how phenotype-based comparisons
between DS mouse models have been useful in analyzing
the relationship of trisomy and DS phenotypes.
Introduction
Trisomy 21 (Ts21) is one of the most prevalent serious
congenital malformations of genetic origin and the most
common human aneuploidy compatible with survival. In
the United States, 1 of every 733 live births has Ts21 (CDC
2006). Worldwide about 220,000 infants with Ts21 are
born each year with phenotypes collectively referred to as
Down syndrome (DS) (Christianson et al. 2006). Individ-
uals with DS have subsets of approximately 80 clinical
phenotypes, including cognitive impairment, craniofacial
dysmorphology, congenital heart defects, gastrointestinal
tract abnormalities, acute megakaryoblastic leukemia,
immunologic defects, endocrine abnormalities, neuropa-
thology leading to dementia, and dysmorphic physical
features. To characterize the variability and origin of the
many characteristic features of DS, multiple phenotypes
have been studied during fetal and postnatal development
(Delabar et al. 2006). The incidence and severity of speciﬁc
DS phenotypes are inﬂuenced by genetic, environmental,
and stochastic factors that occur throughout development
and after birth (Cohen 1999; Epstein 2001).
The long arm of human chromosome 21 (Hsa21) con-
tains 33.7 Mb and approximately 230 genes that are
homologous to syntenic regions of mouse chromosomes
16, 17, and 10 (Fig. 1) (Gardiner et al. 2003). The distal
end of mouse chromosome 16 (Mmu16) contains 144
conserved and minimally conserved Hsa21 orthologs
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http://www.chr21db.cudenver.edu/) (Gardiner et al. 2003;
Nikolaienko et al. 2005), and a number of segmental tri-
somy mouse models have been made with portions of this
chromosomal region at dosage imbalance (Table 1). The
most widely used and well-studied mouse model of trisomy
and DS phenotypes is the Ts(17
16)65Dn (hereafter
Ts65Dn). This segmental trisomy model has a small
translocation chromosome comprising the distal region of
Mmu16 attached to the centromeric end of Mmu17 (Da-
visson et al. 1993; Reeves et al. 1995) and contains about
half of the Hsa21 gene orthologs (Hattori et al. 2000).
Ts65Dn mice show DS-related phenotypes, including re-
duced birth weight, cognitive and behavioral impairments,
craniofacial abnormalities, perinatal lethality, cardiovas-
cular malformations, and neurologic structural deﬁciencies
(Baxter et al. 2000; Belichenko et al. 2004; Cooper et al.
2001; Holtzman et al. 1996; Lorenzi and Reeves 2006;
Moore 2006; Richtsmeier et al. 2000; Roper et al. 2006b;
Rueda et al. 2005). A number of phenotypes characterized
in Ts65Dn mice have been used as a standard to compare
the incidence and severity of trisomic phenotypes in other
mouse models (Aldridge et al. 2007; Arron et al. 2006;
Olson et al. 2004a, 2004b, 2007; Richtsmeier et al. 2002;
Sago et al. 2000; Siarey et al. 2005). Other segmental
trisomies of Mmu16 include Ts(12;16C-tel)1Cje and
Dp(16Cbr1-ORF9)1Rhr (Ts1Cje and Ts1Rhr, respec-
tively). Additional models can be made when a third copy
of a gene or region is added to or subtracted from existing
models. Both Ms1Cje/Ts65Dn and Ms1Rhr/Ts65Dn were
produced by breeding the corresponding monosomy of
newly developed Ts1Cje and Ts1Rhr trisomies to the
existing Ts65Dn mouse (Olson et al. 2004a; Sago et al.
2000). Ts[Rb(12.Ts17
1665Dn)]2Cje (Ts2Cje) mice were
identiﬁed after a fortuitous translocation of the T65Dn
marker chromosome (Villar et al. 2005a). Owing to a
conservation of genetic content and developmental pro-
cesses in human and mouse, the mouse has served as an
effective research model for many DS phenotypes.
Hsa21 genes have also been introduced into mouse cell
lines to produce transchromosomic mice through micro-
cell-mediated chromosome transfer and embryonic stem
cell technology (O’Doherty et al. 2005; Shinohara et al.
2001). The recently developed Tc(Hsa21)1TybEmcf (Tc1)
mouse has germline transmission of an almost intact Hsa21
(proximal and distal gaps omit approximately 10% of
Hsa21 sequence and 8% of Hsa21 genes) but tissue-speciﬁc
variability in cellular trisomy. Tc1 mice exhibit DS-like
neurologic, behavioral, cardiovascular, and craniofacial
abnormalities (O’Doherty et al. 2005).
Additional mouse models with three copies of segments
of mouse chromosomes homologous to Hsa21 have been
used to understand the gene-phenotype relationship of DS.
These models contain dosage imbalance of some Hsa21
orthologs as well as large segments of nonhomologous
genetic material. Trisomy 16 (Ts16) embryos are trisomic
for all of Mmu16 (~98 Mb), including the Hsa21 homol-
ogous region on the distal end of Mmu16, and also contain
trisomic regions homologous to Hsa3, 8, 12, 6, and 22.
Ts16 offspring die perinatally and this has limited studies
in this model to developmental phenotypes, including
edema and fetal cardiac, neurologic, and thymic abnor-
malities (Epstein et al. 1985; Hiltgen et al. 1996; Miyabara
et al. 1982). The Ts(16
17)43H (Ts43H) mouse is trisomic
for 30 Mb of proximal Mmu17 and has been investigated
for DS-related behavioral and gene expression phenotypes
(Vacik et al. 2005). The breakpoint on the T43H segmental
chromosome occurs in the Hsa21 homologous region and
the Ts43H model is trisomic for at least nine Hsa21 or-
thologs found on Mmu17. Because of the large trisomic
Mmu17 region, Ts43H has been estimated to have an
overall greater number of genes at dosage imbalance than
Ts65Dn or Tc1 mice. DS-like phenotypes identiﬁed in the
Ts43H and Ts16 models could be due to three copies of
Hsa21 orthologs, trisomy of large genomic regions, or
trisomic heterogeneity that disturbs distinct pathways but
leads to similar phenotypes.
Fig. 1 Hsa21 and mouse homology, and trisomic mouse models.
Homology of the long arm of Hsa21 is represented on Mmu16, 17,
and 10. The trisomic mouse models show the trisomic Hsa21
homologous regions for each model (striped region for Ts16).
Information is based on mouse build 36, http://www.ensembl.org/
Mus_musculus/index.html, and build 42 of the human genome, http://
www.ensembl.org/Homo_sapiens/index.html
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gous genes or regions at dosage imbalance have also been
created (Altafaj et al. 2001; Ema et al. 1999; Kola and
Hertzog 1997; Roubertoux et al. 2006; Smith et al. 1997).
These models, along with mice that have a speciﬁc gene or
region knocked out or deleted, provide valuable data for
understanding gene function, especially when analyzed in
parallel with segmental trisomy models. Because of dif-
ferences in quantitative gene expression, absence of po-
tential regulatory regions, and limitations of splice variants
in transgenic mice, careful consideration must be given
when analyzing these models. Although single trisomic
genes may have a large effect on a speciﬁc phenotype,
spatial and temporal gene expression must be accurately
compared with segmental trisomy models as well as with
individuals with DS.
The most useful intraspecies assessments compare well-
deﬁned phenotypes of trisomic and control euploid mice at
similar ages or developmental stages, examine identical
tissues, and utilize experimental procedures employing
similar rigor and precise quantiﬁcation (Sago et al. 1998).
Because of genetic differences, it is likely that only a
subset of DS-like phenotypes will be represented in a
mouse model and each model must be thoroughly evalu-
ated for phenotypes that recapitulate the human condition.
Intraspecies comparisons must consider additional factors,
including accurate gene expression, and different patterns
of expression or function of human or mouse genes or
regions in mouse models (Gardiner 2003; Reeves 2006).
Intraspecies comparisons between strains should either use
a similar genetic background (optimally using littermate
euploid control animals) or provide methodologic means to
adjust for differences in genetic background (Olson et al.
2004b; Roper and Reeves 2006; Sago et al. 2000) since it
has been shown that different backgrounds may affect tri-
somic phenotypes (Villar et al. 2005b). Other inherent
differences between trisomic strains include presence/ab-
sence of an extra centromere, potential trisomic maternal
environment during development, and presence of trisomy
in every cell (Box 1). Even with similar rigor, dissimilar-
ities in ﬁndings may be the result of experimental and
methodologic differences or phenotypic variation (Insausti
et al. 1998; Lorenzi and Reeves 2006; Richtsmeier et al.
2000).
Intraspecies comparison: Interaction and modiﬁer loci
The incidence and severity of phenotypes in individuals
with DS is highly variable. The importance of heterotri-
somy (inheritance of multiple nonhomologous alleles) in
speciﬁc regions has been demonstrated to correlate with
pathogenesis in trisomy (Baptista et al. 2000). Incidence
and severity of traits also vary in DS mouse models. For
example, mandibular traits of Ts65Dn were demonstrated
to be more variable in Ts65Dn than euploid mice
(Richtsmeier et al. 2000). Interacting loci from trisomic
regions may be important in producing an equivalent DS-
Table 1 Mouse models of trisomy
Strain Hsa21 homologous
regions at dosage
imbalance
a (Mb)
Hsa21 genes or
orthologs at
dosage
imbalance
b
Percent of
Ts65Dn
trisomic (Mb)
Percent of
Ts65Dn
trisomic genes
Trisomic
offspring at
weaning
Reference
Ts65Dn 13.5 104 100 100 20%–36% Reeves et al. 1995;
Moore 2006;
Roper et al. 2006a
Ts1Cje 8.0 81 59 78 50% Sago et al. 1998
Ms1Cje/Ts65Dn 5.5 22 41 21 23%
c Sago et al. 2000
Ts1Rhr 4.2 33 31 32 NR Olson et al. 2004a
Ms1Rhr/Ts65Dn 9.3 70 69 67 NR Olson et al. 2004a
Ts2Cje 13.5 104 100 100 43% Villar et al. 2005a
Tc1 28.8 ~ 212
d NA NA >40% O’Doherty et al. 2005
Ts16 22.8 144 100+ 100+ NA Miyabara et al. 1982
Ts43H 0.4–0.7
d 9–15
d NA NA 11% Vacik et al. 2005
NA = not applicable; NR = not reported
a Based on mouse build 36, http://www.ensembl.org/Mus_musculus/index.html, and build 42 of the human genome, http://www.ensembl.org/
Homo_sapiens/index.html
b Number of ‘‘conserved’’ plus ‘‘minimally conserved’’ mouse orthologs of Hsa21 genes in each model from chromosome 21 gene function and
pathway database (http://www.chr21db.cudenver.edu/) (Gardiner et al. 2003; Nikolaienko et al. 2005)
c As expected with Ts65Dn/Ts1Cje cross
d As reported in corresponding reference
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123like phenotype. Attenuated phenotypes in different murine
models when trisomic content is reduced is most likely
the result of interacting factors in separate trisomic re-
gions (Olson et al. 2004a, 2007; Sago et al. 1998, 2000).
A single gene with major effect may be modiﬁed by other
trisomic loci, and such interactions may represent genes
deﬁned as sufﬁcient or necessary for a speciﬁc phenotype
(Olson et al. 2004a, 2007; Salehi et al. 2006). Phenotypic
variation also illustrates the possible importance of
interacting loci and intervening nongenic sequences in
determining phenotype (Antonarakis and Epstein 2006;
Antonarakis et al. 2004).
Modiﬁer loci from nontrisomic regions may also impact
incidence and severity of phenotypes. Modiﬁer loci such as
GATA1 and CRELD1 are not located on Hsa21 but have
been shown to have importance in DS childhood leukemia
and heart abnormalities, respectively (Maslen et al. 2006;
Vyas and Crispino 2007). Nontrisomic modiﬁer loci may
also be of importance in mouse models since many triso-
mic models cannot be inbred and therefore are maintained
on a mixed background (O’Doherty et al. 2005; Paz-Mig-
uel et al. 2001; Vacik et al. 2005). The effect of genetic
background on the cardiovascular development of Ts16
embryos indicates that frequency and timing of abnor-
Box 1: Fertility, fecundity, and transmission: an intraspecies comparison 
Practical issues involving trisomic mice vary according to model. Besides genetic content at dosage 
imbalance (Table 1), the availability of mouse models is an important consideration in phenotypic 
observations. In addition, a phenotype may be more robust in a particular model and therefore that model 
may be chosen over other models. Other models may be limited because of new development and limited 
distribution. It is important, however, to examine multiple models for a phenotype. Heart defects in Ts65Dn 
were unknown until recently and followed studies on perinatal loss of Ts65Dn mice independently 
analyzed in our laboratories more than ten years after the Ts65Dn model was first developed and 
characterized (Moore 2006; Roper et al. 2006a). 
Ts65Dn dams, which have reduced reproductive capacity, are utilized for isolation of trisomic 
embryonic tissue, and the effects of development within a trisomic mother cannot be isolated from the 
effects of the trisomy itself. Transmission rates for the T(17
16) 65Dn marker chromosome were reported as 
20%–40%, rather than the 50% expected since the initial characterization of the line. The cause of this 
deficit was speculated to be losses at meiosis, during gestation, and during postnatal life. We showed that 
there was no selection against trisomic gametes, losses begin in the perinatal stages, and there was a 
reduced fecundity in Ts65Dn mothers. Causative evidence was presented for congenital malformations as 
well as poor Ts65Dn mothers. In contrast to the 50% trisomic ratio of progeny at E18, perinatal loss also 
occurs in Ts43H mice with only 11% of the offspring from Ts43H females carrying the segmental trisomy 
as adults (Vacik et al. 2005). In Tc1 mice it was reported that more than 40% of offspring inherited Hsa21 
from their mothers, though the human chromosome was mosaically distributed in the mice. 
Male Ts65Dn mice are considered functionally sterile. Fertility and meiosis in male trisomic mice 
(Ts65Dn, Ts232Dn, Ts4Rk, and Ts2Lws) with an extra segmental trisomic chromosome were compared to 
Ts1Cje mice with the triplicated segment attached to another chromosome (Davisson et al. 2007). The 
presence of an extra chromosome, rather than trisomic genes, and the association of the unpaired 
chromosome with X and Y chromosomes were linked to disrupted spermatogenesis. These results are 
supported by reports of sterile Ts43H males (extra chromosome) and fertile Ts2Cje and Ts1Rhr males 
(T65Dn chromosome fused to the Mmu12 centromere and a duplication of a 4.2-Mb region on Mmu16, 
respectively) (Olson et al. 2004a; Villar et al. 2005a). Interestingly, occasional transmission of Hsa21 
transchromosome from Tc1 male mice was reported (O’Doherty et al. 2005). 
Production of the Ts16 mouse by mating double heterozygotes for two different Mmu16 
Robertsonian translocations should result in one of every six of the progeny inheriting the correct 
chromosomal complement but all such trisomics are lost perinatally (Miyabara et al. 1982). Thus, the 
parental lines must be maintained to perform studies limited to embryonic development of Ts16 mice. 
The Ts2Cje mouse has similar genes at dosage imbalance and trisomic expression levels as 
Ts65Dn (Villar et al. 2005a). In contrast to Ts65Dn, males are fertile and Ts2Cje  mice produce 43% 
trisomic offspring. The morphology of dendritic spines in the fascia dentate was distinguishable from 
euploid littermates and comparable to what was previously seen in Ts65Dn mice (Belichenko et al. 2004). 
Though further phenotypic characterization is necessary, the Ts2Cje model may prove useful in defining 
trisomic phenotypes while overcoming limits of fertility, fecundity, and transmission. 
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123malities in pharyngeal arch arteries vary based on the ge-
netic background in the four strains tested (Villar et al.
2005b). The importance of background and modiﬁer loci
needs to be investigated in future intraspecies studies.
Phenotypic analysis throughout development
Teaming comparative genomic analysis with develop-
mental studies of DS models has the power to uncover the
genesis of a speciﬁc phenotype by identifying where in
development abnormal diverges from normal. Embryonic
studies with Ts16 embryos provided the ﬁrst insights into
the mechanisms by which dosage imbalance of trisomic
genes may impinge upon normal developmental processes
in complex systems such as cardiovascular (Miyabara et al.
1982) and neurologic development (Ozand et al. 1984;
Singer et al. 1984). Identifying the spatial, temporal, and
molecular defects leading to an abnormal phenotype re-
quires precise identiﬁcation and quantiﬁcation (e.g., cell
number, volumetric analysis, complete histologic exami-
nation) since such differences may be small at their
inception and may occur only in a subset of trisomic
individuals. A phenotype-based analysis throughout
development may not only lead to the identiﬁcation of
genes causing the phenotype, but may lead to identiﬁcation
of a particular pathway that may be important for thera-
peutic intervention. A phenotype-based intraspecies com-
parison may offer insight into the gene-phenotype
interaction if development is different among trisomic
models.
Developing trisomic humans and mice have been de-
scribed as ‘‘developmentally delayed’’ (Holtzman et al.
1996; Reeves et al. 1995; Wisniewski 1990). In trisomic
mouse models, this unfortunate nomenclature has often
been used to describe developing and neonatal mice that
are smaller than euploid littermates yet fails to deﬁne
speciﬁc areas of dissimilar development. Ts16 embryos
show reduced brain weight and disrupted neuronal trans-
mitter system development (Ozand et al. 1984; Singer
et al. 1984), reduced number and delayed maturation of
thymocytes (Epstein et al. 1985), and reduced endocardial
mesenchymal cells (Hiltgen et al. 1996) compared with
euploid littermates. To date, little data reﬂect upon the
delays associated with prenatal development in particular
structures at speciﬁc embryonic stages in other trisomic
models. It is unclear if all structures are delayed at the
same developmental point or only those that later become
dysmorphic. If there is a cellular paucity in a structure
during development, is it only because of miscues in gene
expression relating to those particular cells? Does a
phenotypic change in a single population of cells or
structure lead to abnormalities in other cells or structures?
If a structure is ‘‘delayed,’’ does the window of oppor-
tunity for tissue interaction close and thus the derived
tissues can never recover? Is each area of dysmorphology
under separate genetic control? Do many developmental
abnormalities combine to produce a signiﬁcant pheno-
type? These questions remain to be answered by thorough
investigation.
Hypotheses for mechanisms of gene action
Different hypotheses have been presented to account for
the relationship between Ts21 and the occurrence of DS
phenotypes. A number of the most common hypotheses
are presented here, although components of these
hypotheses may not be mutually exclusive. Several genes
are likely to be involved and speciﬁc genes and genetic
mechanisms could differ for an individual phenotype. The
‘‘gene dosage effects’’ model states that three copies of a
particular gene or genes cause increased expression of
speciﬁc transcripts that lead to DS phenotypes. The
‘‘ampliﬁed developmental instability’’ model proposes
that it is not the presence of three copies of a particular
gene but rather the presence of a threshold number of
genes (no matter the genes) that leads to DS phenotypes
(Patterson and Costa 2005). The ‘‘Down syndrome critical
region’’ (DSCR) hypothesis states that genes in a deﬁned
region are responsible for a number of the essential DS
phenotypes (Delabar et al. 1993; Korenberg et al. 1994).
Gene expression analyses have led to hypotheses that the
majority of genetic dysregulation is the product of triso-
mic genes (Mao et al. 2005) or that the increased
expression of trisomic genes leads to a global destabili-
zation in the expression patterns of many disomic genes
(Saran et al. 2003). A few genes may have a major effect
(Arron et al. 2006; Salehi et al. 2006) or an interaction of
many genes with modest affect may underlie the etiology
of a speciﬁc phenotype. Functional noncoding elements in
the genome may also play an important role in DS phe-
notypes (Antonarakis and Epstein 2006; Antonarakis et al.
2004). Intraspecies comparisons of mice with differing
trisomic content illustrate the complexity of the gene-
phenotype relationship in DS, present evidence that inte-
grates many of the ideas from these different hypotheses,
and reﬁnes our understanding of the mechanisms of gene
action leading to speciﬁc DS phenotypes.
Intraspecies comparison of structural and cognitive
phenotypes
Ts21 is the most common genetic cause of mental retar-
dation and cognitive impairment is found in all individuals
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123with DS. By adulthood the brain is microcephalic with
proportionately greater reductions in the hippocampus,
prefrontal cortex, and cerebellum (Epstein 2001; Pen-
nington et al. 2003). Gross structures as well as cellular
components have been quantiﬁed in mouse models to
investigate the association between trisomic brain structure
and function (Belichenko et al. 2004; Cooper et al. 2001;
Holtzman et al. 1996; Kurt et al. 2000; Reeves et al. 1995).
A comparison of the cerebellum and the cerebrum in dif-
ferent trisomic models has suggested interesting connec-
tions between pathology and dosage imbalance. Ts65Dn
mice display a small cerebellum, with a reduction in cer-
ebellar granule cell density that recapitulates the deﬁciency
seen in individuals with DS (Baxter et al. 2000). A dimi-
nution in Purkinje cell density is also characteristic of the
adult Ts65Dn brain. Though there is no apparent reduction
in size of the cerebrum, the shape of the Ts65Dn cerebrum
is different compared with that of euploid littermates
(Aldridge et al. 2007). Ts1Cje mice have a similar reduc-
tion in cerebellar volume as do Ts65Dn mice, but they have
only a slight decrease in cerebellar granule cell density and
no signiﬁcant change in Purkinje cell density (Olson et al.
2004b). Ms1Cje/Ts65Dn mice do not display a signiﬁcant
reduction in cerebellar volume and have a signiﬁcantly
reduced cerebellar granule cell density but no reduction in
Purkinje cell density. A direct comparison between
Ts65Dn, Ts1Cje, and Ms1Cje/Ts65Dn mice revealed that
cerebellar size deﬁcit may not be directly related to the
paucity in granule cell density. The Ts1Rhr cerebellum is
slightly smaller but is not as reduced as either the Ts65Dn
or the Ts1Cje cerebellum, with a shape distinctly different
from euploid littermates (Aldridge et al. 2007; Olson et al.
2004b). Although cerebellar granule cell and Purkinje cell
density is not signiﬁcantly altered, both size and shape of
the cerebrum differ between Ts1Rhr and euploid litter-
mates (Aldridge et al. 2007). Limited studies of Tc1 brain
structure showed a reduction in cerebellar volume and
granule cell density when compared with those of euploid
littermates (O’Doherty et al. 2005). These analyses illus-
trate that speciﬁc brain phenotypes may be under different
genetic control and that a similar pathology may result
from heterogeneous sources or not be related to an obvious
cellular deﬁciency. Different mouse models may be more
useful for an in-depth study of brain phenotypes (e.g.,
Ts65Dn for Purkinje cell deﬁcit and Ts1Rhr for cerebrum
size deﬁcit).
Long-termmemoryresearchhassupportedthenotionofa
hippocampal dysfunction related to DS (Pennington et al.
2003). The hippocampus is thought to be important in
learning and memory, two parameters that are affected in
individuals with DS. Total hippocampal volume is not
changedinTs65Dnmice,thoughreductionsindentategyrus
volume and granule cells have been documented (Insausti
et al. 1998; Lorenzi and Reeves 2006; Rueda et al. 2005).
Like Ts65Dn mice, Ts1Rhr total hippocampal volume is not
decreased compared with that of euploid, although no
quantiﬁcation of Ts1Rhr-speciﬁc hippocampal regions and
cellularconstituentshasbeendone(Olsonetal.2007).When
survival and proliferation of Ts65Dn hippocampal granule
cells were examined in adult mice, no signiﬁcant difference
was observed in either proliferation or survival of granule
cells (Rueda et al. 2005). There were, however, a smaller
number of proliferating cells in the dentate gyrus of older
Ts65Dn mice. Fewer proliferating cells in adult trisomic
brains coupled with the reduction of basal forebrain cholin-
ergic neurons may lead to increased neurodegeneration of
cells in the adult brain (Cooper et al. 2001). No reduction of
volume ofthe dentate gyrus wasseen insix-day-oldTs65Dn
mice, but signiﬁcantly fewer dentate gyrus granule cells and
mitotic cells at six days were found when compared with
euploid littermates. This result suggested that differences in
neurogenesis of granule cells may contribute to the lower
numberofgranulecellsinthedentate gyrus ofTs65Dnmice
(Lorenzi and Reeves 2006).
Changes in hippocampal structure may affect learning
and memory as well as long-term synaptic plasticity
(Galdzicki and Siarey 2003). Ts65Dn mice have been
characterized as hyperactive and with deﬁcits in learn-
ing and memory as deﬁned by the Morris water maze
(Escorihuela et al. 1995; Holtzman et al. 1996; Reeves
et al. 1995). Ts65Dn mice generally decrease the time ta-
ken to locate both visible and hidden platforms in succes-
sive trials (nonspatial and spatial learning, respectively),
although their improvement is signiﬁcantly less than that of
euploid littermates. In the probe trial test, Ts65Dn mice
spend less time in the quadrant that contained the platform.
Ts65Dn, Ts1Cje, and Ms1Cje/Ts65Dn mice were gener-
ated to correlate the genetic contributions of different
Hsa21 homologous regions with behavioral characteristics
associated with DS (Sago et al. 2000). Although none of
the strains were different from euploid controls in the
visible platform test, Ts65Dn, Ts1Cje, and Ms1Cje/
Ts65Dn were all deﬁcient in the hidden platform test
compared with euploid controls. By comparison, Ts65Dn
mice were the most, Ts1Cje were slightly less, and
Ms1Cje/Ts65Dn were somewhat less impaired. Ts65Dn
mice also spent less time in a speciﬁc quadrant test,
whereas Ts1Cje mice were a little more like euploid lit-
termates. In contrast with Ts65Dn, Ts1Cje mice were
found to be hypoactive and Ms1Cje/Ts65Dn mice were not
different than euploid mice in their activity. The most
signiﬁcant differences between Ts65Dn and Ts1Cje mice
were observed in the reverse probe dwell and crossing tests
examining cognitive ﬂexibility. Overall, learning defects in
Ts1Cje mice were similar to but slightly less than those
seen in Ts65Dn mice. Ms1Cje/Ts65Dn mice showed little
436 C.S. Moore and R.J. Roper: Intraspecies comparison of Down syndrome mouse models
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seen in Ts65Dn mice.
Similar results were seen when synaptic plasticity was
compared in Ts65Dn and Ts1Cje strains. Long-term
potentiation (LTP) and long-term depression (LTD) are
physiologic measures associated with learning and memory
(Antonarakis and Epstein 2006). Comparing Ts65Dn and
Ts1Cje mice bred onto a similar background (but not lit-
termates) showed differences between the two strains in
hippocampal electrophysiology (Siarey et al. 1997, 1999,
2005). Ts65Dn mice showed reduction of LTP in CA1 and
dentate gyrus areas and increased LTD in CA1 (Kles-
chevnikov et al. 2004; Siarey et al. 1997, 1999). LTP was
decreased and LTD was increased in Ts1Cje mice but the
overall changes in long-term synaptic plasticity were less
dramatic than those in Ts65Dn mice. The implications
from this study were that the contribution from the trisomic
segment common to Ts65Dn and Ts1Cje was signiﬁcant
for synaptic plasticity but other important interacting genes
are part of the additional trisomic region in Ts65Dn mice.
Interestingly, Tc1 mice with an entirely different genetic
background had a signiﬁcantly reduced LTP in the dentate
gyrus and a trend toward hyperactivity. These results
reﬂect the robustness of these phenotypes even with dif-
ferent potential modifying loci, transchromosomal dissim-
ilarities, including the human origin of the trisomy, and
possible trisomic mosaicism (O’Doherty et al. 2005). Other
tests examining learning and memory still need to be
addressed with the Tc1 model (Reeves 2006). Ts1Rhr mice
showed no deﬁciencies in either Morris water maze or
synaptic plasticity when compared to euploid controls
(Olson et al. 2007). Ts43H mice were not found to be
hyperactive but had spatial learning defects in the Morris
maze test comparable to those seen in Ts65Dn mice (Vacik
et al. 2005). Hyperactivity differences in Ts43H may be
due to necessary Hsa21 orthologs not included in the
Ts43H mice and the spatial learning deﬁcits may mean
additional Hsa21 orthologs or trisomic heterogeneity may
play an important role in these traits.
The structural and functional neuroanatomical studies
reveal that the relationship between trisomic gene content
and DS-related phenotypes may be unique to each pheno-
type. In general, models with less trisomic genetic content
exhibit an attenuated phenotype, including cerebellar size,
Morris swim maze, and synaptic plasticity. Analyses with
Ts65Dn, Ts1Cje, Ts1Rhr, and Ms1Rhr/Ts65Dn mice have
demonstrated that the DSCR concept is incorrect. The
comparative studies between segmental trisomic mice
illustrate that the interaction between genes and/or regions
in two different areas may be important to both the inci-
dence and the severity of structural and functional neuro-
logic phenotypes, thus superseding the ‘‘one gene-one
phenotype’’ hypothesis.
Intraspecies comparison of craniofacial phenotypes
One of the most commonly associated phenotypes of Ts21
is the distinct craniofacial features seen in all individuals
with DS. Using a sophisticated 3D skull analysis of
Ts65Dn mice, Richtsmeier et al. (2000) showed that
Ts65Dn mice exhibit craniofacial abnormalities that
resemble those found in individuals with DS. Similar fea-
tures included microcephaly, brachycephaly, small ﬂat-
tened face, reduced interorbital distance, and both a small
maxilla and mandible. In Ts1Cje mice, more than 80% of
the measurements were conserved between the two models
and affected the same bones of the skull (Richtsmeier et al.
2002). Ts65Dn mice, however, had brachycephaly and
bones were affected to a slightly greater degree. Both
mouse models displayed a smaller mandible than euploid
littermates, with the reduction in size speciﬁc to the coro-
noid and angular processes, and also had slight morpho-
metric changes that are speciﬁc to each strain.
In contrast with Ts65Dn and Ts1Cje mice, Ts1Rhr mice,
with the putative DSCR at dosage imbalance, had a larger
skull and an overall rostrocaudal elongation of the skull
compared with euploid littermates (Olson et al. 2004a).
The mandible of Ts1Rhr mice was larger and had a dif-
ferent shape than Ts65Dn and Ts1Cje mice, with differ-
ences concentrated in the condyle, inferior ramus, and
incisive alveolar. Ms1Rhr/Ts65Dn mice, with all of the
genes at dosage imbalance the same as Ts65Dn except in
the DSCR, showed similar but attenuated effects on the
skull as seen in Ts65Dn and Ts1Cje mice. From these
results, the DSCR was shown to contain genes that were
not sufﬁcient and largely not necessary to cause DS-like
craniofacial abnormalities.
Light microscopy showed no gross differences in the
craniofacial structure of Tc1 mice (O’Doherty et al. 2005).
Simple vector measurements showed no differences in the
skull of Tc1 mice but indicated reduction in mandibular
structurecomparedwitheuploidlittermates.Themandibular
differences speciﬁed trisomic effects in the coronoid and
angular processes similar to Ts65Dn and Ts1Cje mice. Dif-
ferences in methodologies measuring craniofacial structure
may account for additional abnormalities not ascertained in
Tc1 mice. Alternatively, genes important in craniofacial
structure may not have the same expression in the trans-
chromosomic model as found in segmental trisomy models.
At birth, Ts65Dn mice have differences in craniofacial
structure in the anterior face, anterior and posterior
neurocranium, palate, and mandible (Hill et al. 2007).
Although some differences in dysmorphologies were
identiﬁed between adult and newborn Ts65Dn mice, an
analysis of postnatal growth patterns between trisomic and
euploid mice showed that many of these early changes led
to differences seen in adult Ts65Dn mice. It has also been
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Ts65Dn and Ts1Cje mice could be due to developmental
differences between the strains (Richtsmeier et al. 2002).
Similar developmental hypotheses could be extended to
each different model, with differences in the dosage
imbalance of certain genes or regions causing small
developmental alterations of craniofacial structure.
Intraspecies comparisons of cardiac phenotypes
The congenital heart defects (CHD) present in 50% of DS
neonates include atrial, ventricular, and atrioventricular
(AV)septalandvalvardefects(Freemanetal.1998;Wessels
et al. 2003). These malformations are typically attributed to
AV canal abnormalities with failure of proper endocardial
cushionformationorfusionintheinnercurvatureoftheheart
tube of DS individuals. However, complex malformations
also involving the outﬂow tract (e.g., tetralogy of Fallot)
contribute to the cardiac phenotype in many DS cases
(Freeman et al. 1998; Wessels et al. 2003). In a study of DS
neonates undergoing both cardiac physical exam and echo-
cardiography within a month of birth, 66% of this DS group
had detectable cardiac anomalies. AVSD was identiﬁed in
one third of the cases with abnormal echocardiographic
ﬁndings, while tetralogy of Fallot was found in one ﬁfth of
these DS CHD cases (McElhinney et al. 2002). Aberrant
formation or maintenance of the aortic arch arteries, mani-
fested through persistent ductus arteriosus or aberrant right
subclavian artery, also occur at a higher frequency in DS
fetuses and neonates than in the general population (Chaoui
et al. 2005; McElhinney et al. 2002). Studies of DS indi-
viduals with CHD, especially those with segmental trisomy
of only part of Hsa21, have been used to investigate the
molecular basis of the cardiac malformations. Several can-
didate genes mapped to Hsa21 that may contribute to a car-
diac phenotype have been identiﬁed: COLVI (Davies et al.
1994),DSCAM(Barlowetal.2001),andDSCR1(Rothermel
et al. 2000). As yet, no one gene has been found to cause the
complex, variable cardiac anomalies. The presence of an
extra copy of one or more interacting genes from the distal
region of Hsa21 may lead to disruption in the process of
septation. Murine models in which only a subset of the
candidate genes is triplicated may implicate or exclude
several of the current candidate genes as the primary factors
determining the predisposition to cardiac malformations.
The presence or absence of cardiovascular malformation
has been carefully characterized in some but not all DS
models. Cardiovascular abnormalities in Ts16 show com-
plete penetrance, are apparent as septation occurs, and in
some ways parallel the heart defects seen in DS, with more
than half of the embryos displaying a common AV canal
(Miyabara et al. 1982). The cardiovascular phenotype of
Ts16 embryos also demonstrates the limitations of using
whole chromosomal interspecies comparisons to identify
the critical genes at dosage imbalance with analysis of
complex structures derived from multiple tissue types. In
analyzing the Ts16 cardiac phenotype, misalignment of the
endocardial cushions, disruptions in neural crest, and loss
of extracardiac mesoderm that typically contribute to sep-
tation are all posited to contribute to the observed atrio-
ventricular, conotruncal, and atrial septal defects (Waller
et al. 2000; Webb et al. 1997). Yet the right aortic arch and
persistent truncus arteriosus identiﬁed in Ts16 embryos
also resemble the cardiovascular phenotype of DiGeorge
syndrome, a human syndrome associated with deletion of
genetic material from Hsa22q11 (Waller et al. 2000).
Murine genes orthologous to the DiGeorge region of Hsa22
are found on the proximal region of Mmu16 and are trip-
licated in Ts16, but not in trisomies containing only distal
Mmu16 (Ts65Dn, Ts1Cje, and derived lines). Therefore,
the severe cardiac phenotypes characterized in Ts16 may
be viewed as a combination of the mechanisms that con-
tribute to cardiac phenotypes in both DiGeorge and DS.
Attempts to eliminate the cardiovascular phenotype of the
Ts16 mice with reduction of one candidate gene (Dscr1)t o
diploid levels did not signiﬁcantly alter the cardiac phe-
notype (Lange et al. 2005). Ts65Dn lacks the syntenic
Hsa22 region of Mmu16, yet the cardiac abnormalities
identiﬁed thus far in the segmental trisomy include right
aortic arch and intracardiac septal defects (Moore 2006).
The low frequency of gross cardiac anomalies, coupled
with selective loss of trisomic neonates, prevented identi-
ﬁcation of the cardiac phenotype in the Ts65Dn mice. This
DS model had been reported to lack any cardiac phenotype,
so identiﬁcation of a cardiovascular phenotype, albeit at a
low rate, indicates the care that must be taken in charac-
terization of each potential phenotype in each DS model.
Though Ts65Dn mice do not have the severe phenotype of
complete AV canal commonly associated with DS, the
etiology of defects in the great vessels arise with abnormal
formation and/or regression of the aortic arch arteries.
Some aspects of DS CHD, such as tetralogy of Fallot,
persistent ductus arteriosus, and aberrant right subclavian
artery, also have their origins in aortic arch architecture.
Therefore, shared elements of DS, Ts65Dn, and Ts16
cardiac phenotypes suggest some component of the aortic
arch and outﬂow tract malformations may be attributed to
the Hsa21 orthologs on distal Mmu16 .
The cardiac phenotype of the Tc1 mouse at embryonic
day 14.5 (E14.5) resembled the abnormalities typically
seen in DS CHD (O’Doherty et al. 2005). Seven of 11 Tc1
mice had an interventricular septal defect (one with over-
riding aorta), while one had unfused AV cushions. It should
be noted that 20% of the euploid mice also had an inter-
ventricular septal defect and no later stages of development
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the F1 background was approximately 40%, lower than the
50% expected. Because failure of the cardiovascular sys-
tem to form and function properly contributes to perinatal
lethality in mouse and man, the non-Mendelian trisomic
transmission rates seen in multiple DS models may indicate
perinatal lethality of the most severely affected trisomic
embryos due to cardiac or other anomalies.
Other researchers have begun to use the DS model mice
as a primary line from which other transgenic lines may
arise or be speciﬁcally created (Lange et al. 2005; Olson
et al. 2004a; Salehi et al. 2006; Villar et al. 2005a).
Deﬁnitive characterization of the cardiac phenotype in the
Ts65Dn mice and other DS models as primary lines is
crucial for ascertaining the effect of further genetic modi-
ﬁcations produced by secondary modiﬁcations to these
lines. The power of mouse models is that the genomic
complement can be exactly manipulated and deﬁned; we
must therefore be just as exacting in identifying or, just as
important, excluding the presence of DS phenotypes in the
mice. Comparison of trisomic gene content and severity of
cardiac phenotypes between Ts16, Ts65Dn, and other
murine DS models may narrow the candidate regions of
Mmu16, and hence Hsa21, responsible for different com-
ponents (such as AV canal vs. outﬂow tract defects) of the
complex and variable forms of DS CHD.
Gene expression analyses in trisomic mice
Powerful tools to analyze gene expression patterns have re-
vealed a multitude of changes attributed to triplication of
genes, yet results underscore the complexity of analyzing a
multiphenotype, multigene syndrome such as DS. In hu-
mans, microarray analysis of fetal and adult tissue as well as
cell lines derived from individuals with Ts21 show higher
averagegeneexpressionfromHsa21genes(FitzPatricketal.
2002; Giannone et al. 2004; Mao et al. 2003, 2005). The
dysregulationdidnotincludeallgenessampledfromHsa21,
and secondary effects of increased transcript levels were
noted on genes of nontrisomic chromosomes. Tissue-
dependentpatternsofoverexpressionwereobserved,further
illustratingthecomplexityofcorrelatingtrisomicgeneswith
transcript overexpression (Mao et al. 2005).
Gene expression studies in mouse models have shown
similar complexity of results and interpretation. Although
varied tissues and ages of mice were examined, analyses of
neonatal and adult tissues of both Ts65Dn and Ts1Cje mice
showed a near average 1.5-fold overexpression of tripli-
cated genes (Amano et al. 2004; Dauphinot et al. 2005;
Kahlem et al. 2004; Lyle et al. 2004; Saran et al. 2003). In
addition, no average overexpression of genes found in two
copies was seen either from nontriplicated regions of
Mmu16 or the disomic chromosomes. Although average
expression of trisomic genes was generally 1.5-fold, some
genes in three copies were underexpressed, overexpressed
to a greater degree, or unchanged. Differences in gene
expression were speciﬁc to the tissue and developmental
stage of the sample. Signiﬁcant dysregulation of gene
expression in disomic genes was reported in a number of
studies, including one study that illustrated a global sec-
ondary disruption of gene expression due to trisomy (Saran
et al. 2003). In Tc1 E14.5 embryos, microarray analysis on
human arrays showed 39 of 131 Hsa21 genes and only 9 of
22,078 non-Hsa21 probe sets were overexpressed com-
pared with euploid littermates (O’Doherty et al. 2005).
When gene expression was examined in Ts43H mice, 20
brain-speciﬁc genes at dosage imbalance gave an average
of 1.2-fold increased expression of euploid, with expres-
sion of only two genes reaching 1.5-fold expression (Vacik
et al. 2005). In addition, 12 genes on the nontrisomic
portion of chromosome 17 had expression levels that were
90% of euploid level. Brains from Ts2Cje mice exhibited a
1.5-fold expression level of speciﬁc trisomic genes com-
parable to Ts65Dn and different from euploid. Further data
and analyses in both humans and mice are needed to reach
biologically signiﬁcant conclusions (Antonarakis and
Epstein 2006; Reeves 2006).
Applications of an intraspecies approach
A phenotype-based intraspecies comparison of mice will
help to elucidate how Ts21 leads to DS phenotypes. Three
recent examples that examined development of DS-like
phenotypes in mouse models implicated particular genes
and pathways that may be important in speciﬁc phenotypes.
These studies also illustrate the complexity of the gene-
phenotype relationship in DS.
Previous observations in Ts65Dn mice showed an age-
related atrophy and loss of basal forebrain cholinergic
neurons (BFCNs) in the medial septal nucleus (Holtzman
et al. 1996). In Ts65Dn mice, although nerve growth factor
(NGF) levels were greater than normal, NGF retrograde
transport was severely reduced. Normal size and number of
BFCNs were found after delivering NGF directly to the
BFCN cell bodies (Cooper et al. 2001). Retrograde trans-
port of NGF in Ts1Cje mice was about 70% of control and
signiﬁcantly greater than Ts65Dn mice, but no signiﬁcant
differences in size and number of BFCNs nor the abnormal
axonal phenotype were observed in Ts1Cje mice (Salehi
et al. 2006). Protein levels of full-length App, triplicated in
Ts65Dn but not in Ts1Cje mice, were linked to the
abnormal retrograde transport of NGF. NGF transport,
however, was not completely returned to normal in either
Ts1Cje or Ts65Dn mice with only two functioning copies
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abnormal dosage of App combined with the trisomy of
other regions was an important factor in the deﬁcient
transport of NGF and cholinergic neurodegeneration.
Mice with defects in the NFAT signaling pathway
display many phenotypic similarities to DS, including
neurologic, craniofacial, and endocardial cushion abnor-
malities (Arron et al. 2006). Though not all phenotypes
occur in every model, Nfatc2-/-; Nfatc4-/- double knockout
mice display aspects of brachycephaly, midface hypopla-
sia, and dysmorphic mandible. Dscr1, an inhibitor of cal-
cineurin/NFATc signaling, triplicated in Ts65Dn and
Ts1Cje mice, and expressed in higher levels in DS fetuses,
was selected as a candidate gene for craniofacial defects.
Dyrk1a was also selected as a candidate gene and was
shown to regulate the calcineurin/NFAT signaling pathway
in response to ﬁbroblast growth factor 8 (FGF8). Dyrk1a
and Dscr1 were shown to synergistically block NFAT-
dependent transcription. Transgenic overexpression of
Dyrk1a alone and with Dscr1 led to vascular defects and a
failure in heart valve elongation, respectively. Interest-
ingly, cortical neurons of Ts1Cje E13.5 embryos showed
an increase of Dyrk1a expression but whole heads of E11.5
and postnatal day 1 (P1) hippocampal neurons did not have
increased Dyrk1a or Dscr1 protein levels or alterations in
phosphorylation of NFATc. The authors conclude that
during brief developmental periods an increased dosage of
Dscr1 and Dyrk1a reduces NFAT transcriptional activity
and leads to mild versions of NFATc phenotypes.
The above example illustrates the complexity of intra-
species comparison in DS mouse models. Ts1Rhr mice
(trisomic for Dyrk1a but not Dscr1) display craniofacial
defects thatare distinctlydifferentfrom Ts65Dn andTs1Cje
mice (Olson et al. 2004a). Ms1Rhr/Ts65Dn mice (trisomic
for all genes in Ts65Dn except those found in the ‘‘DSCR,’’
including Dscr1) exhibit slightly attenuated craniofacial
abnormalities compared to Ts65Dn and Ts1Cje and do not
have brachycephaly. Furthermore, Tc1 mice have only two
copies of Dscr1 and mandibular abnormalities similar to
Ts65Dn mice. A meta-analysis of all strains on a similar
genetic background, at similar developmental timepoints,
using stringent methodologic analyses will be useful to
understand the complete role of Dyrk1a and Dscr1 in cra-
niofacial structural abnormalities. Similar arguments could
bemadefortheroleofthesegenesinheartdefectsbecauseof
a recent report ﬁnding heart defects in Ts65Dn mice (Moore
2006). Dysregulation of multiple pathways may lead to
similar DS-like phentoypes and it will be important to
understand which pathways are important in Ts21.
Ts65Dn and Ts1Cje mice were used to examine the
origin of the cerebellar size deﬁcit and paucity of granule
cells (Baxter et al. 2000; Olson et al. 2004b). Reduction in
size of the Ts65Dn cerebellum was observed throughout
development until and including P6 (Roper et al. 2006b). A
granule cell deﬁciency was seen throughout development
and traced to a deﬁcit in mitosis of granule cell precursors at
the day of birth. The mitotic deﬁcit was linked to a de-
creased response by trisomic granule cell precursors to so-
nic hedgehog (Shh), a molecule important in proliferation
of granule cell precursors. Treatment of newborn mice with
a Shh pathway agonist overcame deﬁcits in mitosis and the
number of granule cell precursors six days later. Though the
pathogenesis of the cerebellar deﬁcit was described and
linked to a cellular mechanism, the trisomic genetic
mechanism leading to the cellular deﬁcit is still unknown.
Though Shh is not found on Hsa21, it is possible that it may
be linked to many DS phenotypes (Roper et al. 2006b).
Intheseexamplesasinglegeneorpathwaymayprovidea
major factor in the development of a DS-like phenotype. As
noted from the microarray studies, triplication of genes and/
or genomic regions may lead to dysregulation of disomic
genes and a number of different pathways that may appear
unrelated to the initial trisomic insult. A number of distinct
pathways, however, can produce a single phenotype or be
used to correct a phenotype; therefore, therapy derived for a
particular phenotype may involve a pathway that may be
only indirectly disturbed by trisomy. Correlation of gene
misexpression with trisomic phenotypes is among the next
challenges in understanding DS phenotypes.
Conclusions
Comparative analyses of DS mouse models provide a
powerful tool to identify genes that are misregulated by
trisomy, place these genes in pathways leading to pheno-
typic abnormalities, and understand regulatory networks,
including compensation and interaction. In the future,
additional models need to be developed with three copies
of Hsa21 homologous regions not found in current models.
Existing models can be modiﬁed by adding or subtracting
genes or regions to isolate speciﬁc gene-phenotype rela-
tionships. In future comparative studies, it is important to
examine tissues at multiple timepoints during development
and to use identical and robust methodologies. Intraspecies
phenotype-based analyses show promise in ﬁnding ways to
deﬁne phenotypic etiology and to ameliorate or prevent
speciﬁc DS phenotypes.
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